Premier Alternatives

Inanovate

Sioux Falls, SD · Founded 2006 · Privately Held (backing)

Developer of longitudinal assay screening technology designed for the detection and measurement of multiple proteins. Inanovate is based in Sioux Falls, SD and was founded in 2006. Its last reported valuation was $11.8 million in Feb 2022. It has raised $10.1 million across 9 recorded rounds; the latest was an $808,000 seed round in Mar 2025.

Last reported valuation
$11.8M
Oct 2026
Priced at
—
Total raised
$10.1M
Last round
Seed Round
Mar 2025

Inanovate key facts

as of Oct 2026
  • Developer of longitudinal assay screening technology designed for the detection and measurement of multiple proteins.
  • Inanovate is valued at approximately $11.8M as of Oct 2026 (last reported valuation).
  • It has raised $10.1M across 9 recorded rounds; the latest was Seed Round ($808K) in Mar 2025.
  • Notable investors include US National Science Foundation, Denny Sanford, National Cancer Institute, Sanford Frontiers, University of Birmingham.
  • Inanovate has filed 9 Form Ds with the SEC since 2019, most recently Jul 2025 ($808K sold to 2 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$11.8M

Inanovate's last reported valuation, Feb 2022. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Inanovate with a free account
  • ·Watch Inanovate: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Inanovate funding rounds

9 rounds
Mar 2025Seed Round$808KSEC filing▮
Nov 2024Seed Round$900KSEC filing▮
May 2024Seed Round$1.1MSEC filing▮
Dec 2023Seed Round$1.5MSEC filing▮
Oct 2022Seed Round$2.4MSEC filing▮
Full funding history →

Inanovate valuation

Inanovate's last reported valuation was $11.8 million in Feb 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Inanovate raised?

Inanovate has raised $10.1 million across 9 recorded rounds since 2019. The largest was a $900,000 seed round in Nov 2024; the most recent was an $808,000 seed round in Mar 2025.

Inanovate has filed 9 Form Ds with the SEC since 2019, most recently in Jul 2025 ($808,000 sold to 2 investors).

Inanovate investors

5 investors are on record for Inanovate, including US National Science Foundation, Denny Sanford, National Cancer Institute and Sanford Frontiers. The seed round in Mar 2025 drew 2 investors.

About Inanovate

Developer of longitudinal assay screening technology designed for the detection and measurement of multiple proteins. The company's technology offers to test and benchmark Bio-ID which consists of a compact bench-top analyzer and disposable test cartridges for precisely measuring the concentration of multiple disease-related biological molecules from patient blood samples, helping patients to lower the cost and improve the accuracy of diagnostic tests.

Sector
Healthcare
HQ
Sioux Falls, SD, United States
Founded
2006
Employees
19
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.